Back to top
more

eHealth (EHTH)

(Delayed Data from NSDQ)

$4.55 USD

4.55
208,302

-0.02 (-0.33%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $4.53 -0.02 (-0.44%) 6:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (34 out of 252)

Industry: Insurance - Brokerage

Better trading starts here.

Zacks News

eHealth (EHTH) Q4 Earnings Miss on Higher Operating Costs

eHealth (EHTH) expects revenues to be in the range of $450-$475 million in 2024.

EHealth (EHTH) Misses Q4 Earnings Estimates

eHealth (EHTH) delivered earnings and revenue surprises of -17.01% and 1.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Exploring the Driving Forces Behind eHealth's (EHTH) Q4 Earnings

eHealth's (EHTH) fourth-quarter 2023 results are likely to reflect higher expenses and Individual, Family and Small Business segment revenues.

eHealth (EHTH) Surges 20.8%: Is This an Indication of Further Gains?

eHealth (EHTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Aon (AON) Q3 Earnings and Revenues Beat Estimates

Aon (AON) delivered earnings and revenue surprises of 4.04% and 2.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Willis Towers Watson (WTW) Q3 Earnings and Revenues Top Estimates

Willis Towers Watson (WTW) delivered earnings and revenue surprises of 8.21% and 4.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now

eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.

eHealth (EHTH) Soars 13.7%: Is Further Upside Left in the Stock?

eHealth (EHTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

eHealth (EHTH) Revises 2023 Guidance: Here's What We Think

eHealth (EHTH) anticipates its adjusted EBITDA for 2023 to be within a loss of $3 million and a profit of $17 million, which shows significant improvement from the previous guidance.

EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates

eHealth (EHTH) delivered earnings and revenue surprises of -10.53% and 33.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Ryan Specialty Group (RYAN) Q2 Earnings and Revenues Top Estimates

Ryan Specialty (RYAN) delivered earnings and revenue surprises of 7.14% and 2.17%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Willis Towers Watson (WTW) Q2 Earnings Lag Estimates

Willis Towers Watson (WTW) delivered earnings and revenue surprises of -13.87% and 1.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Why You Should Consider Buying Brown & Brown (BRO) Stock

New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position poise Brown & Brown (BRO) for growth.

eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?

Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).

eHealth (EHTH) Targets 8-10% Adjusted EBITDA Margin by 2025

By the trailing 12-month period ending March 2025, eHealth (EHTH) expects to enter the positive operating cash flow region.

EHealth (EHTH) Reports Q1 Loss, Misses Revenue Estimates

eHealth (EHTH) delivered earnings and revenue surprises of -21.52% and 20.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Ryan Specialty Group (RYAN) Q1 Earnings and Revenues Beat Estimates

Ryan Specialty (RYAN) delivered earnings and revenue surprises of 13.04% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Willis Towers Watson (WTW) Tops Q1 Earnings and Revenue Estimates

Willis Towers Watson (WTW) delivered earnings and revenue surprises of 1.07% and 2.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Brown & Brown (BRO) Q1 Earnings and Revenues Beat Estimates

Brown & Brown (BRO) delivered earnings and revenue surprises of 3.70% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Marsh & McLennan (MMC) Surpasses Q1 Earnings and Revenue Estimates

Marsh & McLennan (MMC) delivered earnings and revenue surprises of 3.27% and 1.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Arthur J. Gallagher (AJG) Closes Buck Buyout, Boosts Portfolio

Arthur J. Gallagher (AJG) bought partnership interest in BCHR Holdings, L.P., dba Buck and its subsidiaries for $660 million to consolidate its portfolio of professional services.

Brown & Brown (BRO) Boosts Canada Presence With HBG Buyout

Brown & Brown's (BRO) buyout of Highcourt Partners is likely to provide it solid opportunities and a robust leadership team to boost growth in Canada.

Is Euronet Worldwide (EEFT) Stock Outpacing Its Finance Peers This Year?

Here is how Euronet Worldwide (EEFT) and eHealth (EHTH) have performed compared to their sector so far this year.

eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y

eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.

EHealth (EHTH) Q4 Earnings and Revenues Surpass Estimates

eHealth (EHTH) delivered earnings and revenue surprises of 147.83% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?